ETON Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress OMF Q1 2026 Earnings EPS Beat Drives Modest Share Price Uptick VHC Q2 2025 Earnings Net Loss of 099 Per Share as Stock Surges on Strategic Developments Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Significant EPS Miss Amid PreClinical Stage Operations VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion